Next Financial Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $745K | Buy |
1,977
+717
| +57% | +$270K | 0.05% | 396 |
|
|
2021
Q3 | $520K | Buy |
1,260
+108
| +9% | +$44.6K | 0.04% | 450 |
|
|
2021
Q2 | $426K | Buy |
1,152
+13
| +1% | +$4.81K | 0.03% | 535 |
|
|
2021
Q1 | $330K | Buy |
1,139
+47
| +4% | +$13.6K | 0.03% | 579 |
|
|
2020
Q4 | $273K | Sell |
1,092
-3
| -0.3% | -$750 | 0.03% | 597 |
|
|
2020
Q3 | $248K | Sell |
1,095
-198
| -15% | -$44.8K | 0.03% | 550 |
|
|
2020
Q2 | $225K | Sell |
1,293
-194
| -13% | -$33.8K | 0.03% | 496 |
|
|
2020
Q1 | $188K | Sell |
1,487
-224
| -13% | -$28.3K | 0.02% | 559 |
|
|
2019
Q4 | $261K | Sell |
1,711
-40
| -2% | -$6.1K | 0.03% | 597 |
|
|
2019
Q3 | $232K | Sell |
1,751
-268
| -13% | -$35.5K | 0.03% | 609 |
|
|
2019
Q2 | $286K | Buy |
2,019
+90
| +5% | +$12.7K | 0.03% | 538 |
|
|
2019
Q1 | $280K | Buy |
+1,929
| New | +$280K | 0.07% | 278 |
|